ION Exchange (India) Limited has informed the Exchange about Transcript of the Conference Call held on Monday, August 10, 2026

AI summary - Q1 FY27 consolidated revenue 701cr +20% y-y; EBITDA 32cr -49% y-y; PAT 3cr; EBITDA margin 4.54%, PAT margin 0.44% - Treatment Solutions revenue 210cr +14% y-y; EBIT loss 17cr due to legacy projects - Industrial Products revenue 105cr +14% y-y; EBIT 13cr; margin 11.89% vs <6% last year - Lifecycle Services revenue 72cr +28% y-y; EBIT 7cr; margin 9.92% - Specialty Chemicals revenue 230cr +21% y-y; EBIT 22cr -52% y-y; impacted by Roha plant costs and geopolitical factors - Consumer Products revenue 112cr +33% y-y; loss narrowed to 0.34cr - Order book 2473cr (excludes recent 500cr Hyundai contract); bid pipeline 9777cr - Roha resin plant capacity expansion to 5x original; pharma resin capacity expanding 6x - Focus on advanced, emerging water solutions, international growth, and improving profitability - Legacy projects impacting Treatment Solutions profitability; expected to improve as projects complete - Management targets break-even in Consumer Products this year - WQA certification and new leadership to boost North America growth - Input costs expected to moderate with crude price stabilization - Lifecycle Services segment aims for asset-light, repeatable revenue model - Management cautious but optimistic on margin recovery and growth trajectory